| Name | (5R)-1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine |
|---|---|
| Synonyms |
Dextofisopam [USAN:INN]
(+)-Tofisopam (R)-1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-hydroxy-8-methoxy-5H-2,3-benzo-diazepine (R)-1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine Dextofisopam (R)-1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3-benzodiazepine R-Tofisopam |
| Density | 1.15g/cm3 |
|---|---|
| Boiling Point | 479ºC at 760 mmHg |
| Molecular Formula | C22H26N2O4 |
| Molecular Weight | 382.45300 |
| Flash Point | 195.2ºC |
| Exact Mass | 382.18900 |
| PSA | 61.64000 |
| LogP | 3.31270 |
| Index of Refraction | 1.558 |
|
~84%
82059-50-5 |
| Literature: Vela Pharmaceuticals, Inc. Patent: US2004/254174 A1, 2004 ; Location in patent: Page 15 ; |
|
~%
82059-50-5 |
| Literature: Vela Pharmaceuticals, Inc. Patent: US2004/254174 A1, 2004 ; Location in patent: Page 14 ; |